Tekguc, Murat
Matsumoto, Takuya
Altenburger, Lukas M.
Kobayashi, Kenichi
Hiratsuka, Ken
Higashi, Yuhei
Rizki-Safitri, Astia
Miyoshi, Tomoya
El-Jouni, Wassim
Arnaout, M. Amin
Mempel, Thorsten R.
Morizane, Ryuji
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases
Article History
Received: 2 July 2025
Accepted: 16 December 2025
First Online: 2 February 2026
Competing interests
: The authors declare no competing financial interests but the following competing non-financial interests. R.M. is an inventor on patents filed by the President and Fellows of Harvard College and Mass General Brigham (PCT/US2018/036677 licensed to Trestle Biotherapeutics, PCT/US23/73271, and PCT/US23/71029). R.M. holds a stock option in Trestle Biotherapeutics. R.M. served as a consultant to Toray Industries and Ajinomoto.